Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

NCT02418494 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT02418494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02418494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
Lead sponsor
AIDS Malignancy Consortium
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2016
Enrollment
85 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

high grade anal canal squamous intraepithelial neoplasia, hiv infection